Catalyst Wire Dossier Catalyst Wire Dossier

Long-acting naltrexone

naltrexone
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Long-acting naltrexone, covering 2022-12-02 to 2022-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery [Phase 4]

See pricing